Author:
Moriya Kunihiko,Matsuhashi Tetsuro,Onuma Masaei,Niizuma Hidetaka,Rikiishi Takeshi,Asada Hiroshi,Suzuki Jun,Sasahara Yoji,Kure Shigeo
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Heisel MA, Ortega JA. Factors influencing prognosis in childhood autoimmune hemolytic anemia. Am J Pediatr Hematol Oncol. 1983;5:147–52.
2. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, et al. Depletion of B-cells in vivo by a chimeric mouse monoclonal antibody to CD20. Blood. 1994;83:435–45.
3. Giulino LB, Bussel JB, Neufeld EJ. Treatment with Rituximab in benign and malignant hematologic disorders in children. J Pediatr. 2007;150:338–44.
4. Quartier P, Brethon B, Philippet P, Landman-Parker J, Le Deist F, Fischer A. Treatment of childhood autoimmune hemolytic anemia with rituximab. Lancet. 2001;358:1511–3.
5. Zecca M, Nobili B, Remenghi U, Perrotta S, Amendola G, Rosito P, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood. 2003;101:3857–61.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献